WITHDRAWN: Metformin mitigates cisplatin-induced ovarian damage through inhibiting the pyroptosis of granulosa cells via ROS/TXNIP/NLRP3 signaling pathway
单位:[1]Department of Obstetrics and Gynecology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China.华中科技大学同济医学院附属同济医院妇产科教研室妇产科学系[2]National Clinical Research Center for Obstetrical and Gynecological Diseases, Wuhan 430030, China.[3]Key Laboratory of Cancer Invasion and Metastasis, Ministry of Education, Wuhan 430030, China.[4]Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan 430030, China.[5]Department of Medical Oncology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China.
This paper was originally published in Aging Advance Online Publications on March 14, 2024. In compliance with Aging's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Aging internal or any external indexes or archives.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|3 区医学
小类|3 区细胞生物学3 区老年医学
最新[2025]版:
无
第一作者:
第一作者单位:[1]Department of Obstetrics and Gynecology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China.[2]National Clinical Research Center for Obstetrical and Gynecological Diseases, Wuhan 430030, China.[3]Key Laboratory of Cancer Invasion and Metastasis, Ministry of Education, Wuhan 430030, China.
推荐引用方式(GB/T 7714):
Wang Bo,Li Jian,Zhang Qianyu,et al.WITHDRAWN: Metformin mitigates cisplatin-induced ovarian damage through inhibiting the pyroptosis of granulosa cells via ROS/TXNIP/NLRP3 signaling pathway[J].Aging.2024,16:doi:10.18632/aging.205659.
APA:
Wang Bo,Li Jian,Zhang Qianyu,Li Yuting,Ren Wu&He Du.(2024).WITHDRAWN: Metformin mitigates cisplatin-induced ovarian damage through inhibiting the pyroptosis of granulosa cells via ROS/TXNIP/NLRP3 signaling pathway.Aging,16,
MLA:
Wang Bo,et al."WITHDRAWN: Metformin mitigates cisplatin-induced ovarian damage through inhibiting the pyroptosis of granulosa cells via ROS/TXNIP/NLRP3 signaling pathway".Aging 16.(2024)